Axsome Therapeutics (AXSM) PT Raised to $220 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Axsome Therapeutics (AXSM) PT Raised to $230 at B.Riley
January 2, 2026 9:37 AM ESTB.Riley analyst Madison El-Saadi raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $230.00 (from $184.00) while maintaining a Buy rating.
... MoreBaird on Axsome Therapeutics (AXSM): 'Incrementally positive on regulatory updates'
December 31, 2025 1:54 PM ESTBaird analyst Joel Beatty reiterated an Outperform rating and $157.00 price target on Axsome Therapeutics (NASDAQ: AXSM).
The analyst comments "Incrementally positive on regulatory updates. Axsome announced two New Year's Eve regulatory updates, with their sNDA for AXS-05 (Auvelity) in Alzheimer's agitation... More
Leerink on Axsome Therapeutics (AXSM): 'This is very positive news'
December 31, 2025 1:20 PM ESTLeerink Partners analyst Marc Goodman reiterated an Outperform rating and $150.00 price target on Axsome Therapeutics (NASDAQ: AXSM).
The analyst comments "This is very positive news for Axsome, as Alzheimer's disease agitation (AD-A) is a key additional indication to drive... More
